Glucotrack Achieves Significant ISO Certification Milestone

Glucotrack Achieves ISO 13485:2016 Certification

Glucotrack, Inc. (NASDAQ: GCTK), a pioneering medical technology company, has reached a significant milestone by obtaining ISO 13485:2016 certification. This achievement was officially recognized by the British Standards Institute (BSI) and marks a pivotal moment in Glucotrack's commitment to developing high-quality solutions for diabetes management.

Importance of ISO Certification

ISO 13485 is a globally acknowledged standard that underscores the importance of effective quality management systems specifically for medical devices. It goes beyond the general ISO 9001 standard by emphasizing regulatory compliance crucial for medical industry operations. The new certification aligns Glucotrack with stringent international quality standards, ensuring that its innovative Continuous Blood Glucose Monitor (CBGM) meets the highest safety and efficacy criteria.

CEO Statement on ISO Certification

Paul V. Goode, PhD, President and CEO of Glucotrack, expressed his enthusiasm regarding the certification. He noted, "This ISO certification is a significant step in our journey toward delivering high-quality products. Meeting these rigorous global standards demonstrates our commitment to quality and regulatory excellence as we achieve clinical milestones for our revolutionary CBGM designed for individuals with diabetes."

Steps to Achieve Certification

To obtain this esteemed certification, Glucotrack successfully navigated a thorough evaluation process involving Stage I and Stage II Assessments conducted by BSI. This rigorous assessment verified that the company has implemented and upholds a quality management system that adheres to all requirements set forth by the ISO 13485:2016 standard. Such dedication not only reflects the company's operational integrity but also its resolute focus on patient safety and product reliability.

Global Standards Influence

The significance of ISO 13485 extends globally. Following the U.S. Food and Drug Administration's introduction of the Quality Management System Regulation (QMSR) Final Rule, the adoption of ISO 13485 has been strongly recommended not just in the United States but worldwide, particularly in the European Union. This harmonization of standards fosters an efficient regulatory landscape that benefits companies, stakeholders, and most importantly, the patients.

Innovative Technology for Diabetes Management

Glucotrack is at the forefront of technological advancements for people living with diabetes. The company is actively developing a long-term, implantable continuous blood glucose monitoring system that stands out due to its unique features: a sensor longevity of three years, no necessity for an on-body wearable part, and minimal calibration. This technology is aimed at providing a hassle-free and reliable solution for diabetes management.

What to Expect from Glucotrack

As Glucotrack continues its development in the medical technology field, the ISO 13485:2016 certification serves as a formidable foundation for achieving future regulatory approvals and commercial success. The advancements in their CBGM technology hint at a transformative impact on the diabetes community, allowing for better management possibilities that could enhance the quality of life for many patients.

About Glucotrack, Inc.

Glucotrack, Inc. is dedicated to the design, development, and commercialization of innovative technologies aimed specifically at individuals with diabetes. The focus on creating efficient and effective monitoring solutions positions the company as a leader in the diabetes care market.

Frequently Asked Questions

What is ISO 13485:2016 certification?

ISO 13485:2016 certification is a recognition that a company adheres to international standards for quality management systems in the medical device industry, ensuring product safety and effectiveness.

Why is this certification significant for Glucotrack?

This certification validates Glucotrack's commitment to producing high-quality diabetes management solutions, enhancing its credibility in regulatory processes and market competitiveness.

What products is Glucotrack developing?

Glucotrack is working on an innovative long-term implantable continuous blood glucose monitoring system designed to improve how patients monitor their glucose levels.

How does ISO 13485 impact patient care?

By adhering to ISO 13485 standards, Glucotrack ensures that its products meet rigorous safety and performance criteria, which translates into better health outcomes for patients using their devices.

Where can I learn more about Glucotrack's products?

For additional information about Glucotrack and its innovative CBGM technology, please visit their official website at glucotrack.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. If any of the material offered here is inaccurate, please contact us for corrections.